Analytical Data
-
Gene name
ZBTB7A
- Application
-
Alternative Names
FBI1; LRF; ZBTB7; ZNF857A
-
Species
Human
-
Source
E. coli
-
Tag
His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O95365
-
Expression Region
M1-I149
-
Protein Length
Partial
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ZBTB7A, a member of the ZBTB (zinc finger and BTB domain-containing) family of transcription factors, plays a significant role in various biological processes, including cell differentiation, proliferation, and immune response regulation. Research into ZBTB7A has gained momentum due to its implications in several diseases, notably cancer and autoimmune disorders. It is involved in regulating gene expression through its ability to bind to specific DNA sequences and interact with other proteins. The reconstitution of ZBTB7A as a recombinant protein enables researchers to dissect its molecular functions, study its protein-protein interactions, and explore its effects on downstream signaling pathways. Understanding the structure and function of ZBTB7A at a molecular level may reveal insights into its role in pathophysiology and facilitate the development of targeted therapeutic strategies. The development of recombinant ZBTB7A also offers potential applications in the fields of biotechnology and medicine, allowing for the exploration of its utility as a biomarker or therapeutic target. Overall, the ongoing research into ZBTB7A and its recombinant protein provides valuable contributions to our understanding of gene regulation and its implications in health and disease.
